483
Biomat USA, Inc.FDA 483 - Biomat USA, Inc. - June 18, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of DB Biologics, LLC in Harrisburg, PA, a source plasma donor center, revealed a significant issue regarding the preparation of phlebotomy sites. The firm failed to ensure sterile venipuncture sites for donor blood collections, as phlebotomists were observed palpating prepared areas before proceeding with collections. This practice compromises the sterility of blood products.
Open in Dashboard
ID · a496971e-5ba1-498d-8002-b4dcfeb3c8f6